List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 81 studies with search of: Flushing | Open Studies
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Alternative Options to Minimize Niacin-Induced Flushing
Conditions: Hypercholesterolemia;   Flushing
Interventions: Other: Apple pectin;   Drug: Aspirin 325 mg;   Other: Apple pectin 2000 mg + aspirin 325 mg;   Other: Placebo
2 Recruiting Extended Interval Port Flushes for Subjects With a Routine Practice of Having Their Ports Flushed Every 4 to 6 Weeks
Condition: Patients With Catheters/Ports Receiving Chemotherapy
Intervention: Device: port flushes
3 Recruiting Role of Prostaglandins on Niacin-Induced Flushing
Condition: Flushing
Intervention: Drug: Niacin and aspirin
4 Recruiting Pilot Study of Stellate Ganglion Injection to Provide Relief From Hot Flushes
Conditions: Hot Flashes;   Menopause
Interventions: Procedure: Sympathetic nerve block with 1% lidocaine 1-2 ml;   Procedure: Superficial subcutaneous injection
5 Not yet recruiting A Double-Blind Study to Evaluate the Effect of Femarelle® on Menopausal on Vasomotor Symptoms
Conditions: Menopause;   Hot Flashes
Interventions: Dietary Supplement: Femarelle;   Dietary Supplement: Placebo
6 Recruiting Study to Test GSK256073 in Patients With Dyslipidemia
Condition: Dyslipidaemia
Interventions: Drug: Niaspan;   Drug: GSK256073;   Drug: Placebo
7 Recruiting Menopause and Meditation for Breast Cancer Survivors
Condition: Menopause
Intervention: Behavioral: Mindfulness Meditation
8 Recruiting Chinese Medicine Therapy on Menopausal Symptoms
Condition: Menopause
Intervention: Other: Er-xian Decoction
9 Recruiting A Long-term Study of ERN/LRPT (Extended Release Niacin/Laropiprant (MK0524A)) in Patients With Dyslipidemia
Condition: Dyslipidemia
Interventions: Drug: ER niacin (+) laropiprant (ERN/LRPT);   Drug: Comparator: ER niacin (+) laropiprant (ERN/LRPT);   Drug: Comparator: Extended-release niacin (ERN);   Drug: Comparator: Placebo to ERN/LRPT
10 Recruiting Hemodialysis Without Anticoagulation in Intensive Care Unit
Conditions: Kidney Failure;   Critically Ill;   Hemorrhage
Intervention: Device: AN69 ST
11 Not yet recruiting Flushing in Social Anxiety Disorder on Seroquel
Condition: Social Anxiety Disorder
Interventions: Drug: Seroquel;   Other: Sugar Pill
12 Not yet recruiting Flushing in Social Anxiety Disorder on Cipralex
Condition: Social Anxiety Disorder
Interventions: Drug: Cipralex;   Drug: Placebo
13 Recruiting The Safety and Efficacy of CPTK787/ZK222584 in Patients With Metastatic Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Intervention: Drug: PTK787/ZK222584
14 Not yet recruiting Cognitive Behavioral Therapy (CBT) and Physical Exercise for Climacteric Symptoms in Breast Cancer Patients Experiencing Treatment-Induced Menopause: a Multicenter Randomized Trial
Condition: Menopausal Symptoms in Breast Cancer Patients With Treatment-Induced Complaints
Interventions: Behavioral: CBT and relaxation;   Behavioral: Physical activity;   Behavioral: CBT and physical activity;   Other: Control group
15 Not yet recruiting An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia
Condition: Social Anxiety Disorder
Intervention: Drug: Omega 3 Joy enteric coated concentrated fish oil
16 Recruiting Ethanol Locks for the Treatment of Central Venous Line Infections
Condition: Bloodstream Infection
Interventions: Drug: 70% ethanol;   Drug: heparin flush solution
17 Not yet recruiting Efficacy and Safety of S-Equol on Vasomotor Symptoms in Menopausal Patients
Condition: Menopause
Interventions: Drug: S-equol;   Drug: Placebo
18 Recruiting Efficacy and Safety of Masitinib (AB1010) in Comparison to Placebo in the Treatment of Patients With Smouldering Systemic, Indolent Systemic or Cutaneous Mastocytosis With Handicap
Conditions: Smouldering Systemic Mastocytosis;   Indolent Systemic Mastocytosis;   Cutaneous Mastocytosis With Handicap;   Mastocytosis
Interventions: Drug: masitinib (AB1010);   Drug: placebo
19 Not yet recruiting Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome
Condition: Carcinoid Syndrome
Intervention: Drug: BIM 23A760
20 Not yet recruiting Effect of Tredaptive on Serum Lipoproteins and Inflammatory Markers
Condition: Hypercholesterolemia
Intervention: Drug: nicotinic acid/laropiprant

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services